Follow-The-Filings

Security · featured owners

UTHR United Therapeutics Corp.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 14.3%
  • $71M
  • 2 reduce 1 exit

UTHR (United Therapeutics Corp.) is held in 2 featured 13F books as of 2026 Q2. Michael Krensavage - Krensavage Asset Management is the largest tracked holder by portfolio weight (14.3%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 14.3% (Michael Krensavage - Krensavage Asset Management) · not free-float ownership

  1. Michael Krensavage reduce 14.3%
  2. Palo Alto Investors reduce 4.7%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Michael Krensavage - Krensavage Asset Management 2026 Q2 14.3% Reduce −17.8% 69,282 $38M history
Palo Alto Investors 2026 Q2 4.7% Reduce −0.4% 62,587 $34M history
Mairs & Power exited 2026 Q2 last 2026 Q1 <0.01% Exit 0.00% 350 $208K history

2 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 3 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 1.01,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 23 rows shown

Filed Form Detail Links
4 Period Sep 15, 2026 Filing Doc
4 Period Sep 14, 2026 · 2 forms Filing Doc
4 Period Sep 11, 2026 Filing Doc
4 Period Sep 10, 2026 Filing Doc
4 Period Sep 9, 2026 Filing Doc
4 Period Sep 8, 2026 Filing Doc
4 Period Sep 4, 2026 Filing Doc
4 Period Sep 3, 2026 Filing Doc
4 Period Sep 2, 2026 Filing Doc
4 Period Sep 3, 2026 Filing Doc
4 Period Sep 1, 2026 Filing Doc
4 Period Aug 31, 2026 Filing Doc
4 Period Aug 28, 2026 Filing Doc
4 Period Aug 27, 2026 Filing Doc
4 Period Aug 26, 2026 Filing Doc
4 Period Aug 25, 2026 Filing Doc
4 Period Aug 24, 2026 Filing Doc
4 Period Aug 21, 2026 Filing Doc
4 Period Aug 20, 2026 · 2 forms Filing Doc
4 Period Aug 19, 2026 Filing Doc
4 Period Aug 18, 2026 Filing Doc
4 Period Aug 17, 2026 Filing Doc
4 Period Aug 14, 2026 Filing Doc

Updated about 13 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.33B $2.88B $3.18B
Gross profit $2.07B $2.57B $2.8B
Gross margin * 88.9% 89.2% 87.9%
Net income $0.985B $1.2B $1.33B
Net margin * 42.3% 41.5% 41.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $3.55B $3.87B $3.7B
Total non-current assets * $3.62B $3.49B $4.18B
Total assets $7.17B $7.36B $7.88B
Total current liabilities $804.4M $738.1M $560.6M
Total non-current liabilities * $377.8M $181.9M $223.2M
Total equity $5.98B $6.44B $7.1B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $0.978B $1.33B $1.56B
Cash from investing -$719.6M $417.2M -$551.3M
Cash from financing -$0.012B -$1.25B -$1.15B
Net change in cash $246.5M $489.5M -$140.1M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders